State Street’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

State Street’s Portfolio CHTP Stock Details CHTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-4,174,872	Closed	-$23M	–	3714
2014 Q1	$23M	Buy	4,174,872 +2,984,052	+251%	+$15M	﹤0.01%	1675
2013 Q4	$5.28M	Buy	1,190,820 +445,561	+60%	+$1.51M	﹤0.01%	2552
2013 Q3	$2.24M	Buy	745,259 +79,693	+12%	+$229K	﹤0.01%	2977
2013 Q2	$1.53M	Buy	+665,566	New	+$1.35M	﹤0.01%	3091

Other funds holding CHTP

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

State Street's CHTP Position: Q2 2014 in Review

State Street sold out of CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q2 2014, closing a stake of 4,174,872 shares — an estimated $23M sold.

State Street first reported a position in CHTP in Q2 2013 and held it in 4 quarters. The position peaked at $23M in Q1 2014. 6 funds tracked by Wall St. Rank hold CHTP as of Q2 2014.

State Street reported no remaining CHELSEA THERAPEUTICS INT'L LTD position as of Q2 2014 after selling out during the quarter.
State Street sold 4,174,872 CHELSEA THERAPEUTICS INT'L LTD shares in Q2 2014, an estimated $23M.
State Street first reported a position in CHELSEA THERAPEUTICS INT'L LTD in Q2 2013 and held it in 4 quarters.
State Street's CHELSEA THERAPEUTICS INT'L LTD position peaked at $23M in Q1 2014.
6 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q2 2014.

Based on State Street's 13F filing for Q2 2014, filed 12 Aug 2014.